Operationalization of rapid molecular test coverage for tuberculosis in different international contexts: a scoping review
Authors:
- Diogo Henrique Mendes da SilvaDSDiogo Henrique Mendes da Silva
- Ana Beatriz Marques ValençaAVAna Beatriz Marques Valença
- Melisane Regina Lima FerreiraMFMelisane Regina Lima Ferreira
- Mariana Gaspar Botelho Funari de FariaMFMariana Gaspar Botelho Funari de Faria
- Rubia Laine de Paula AndradeRARubia Laine de Paula Andrade
- Rebeca Sousa BragaRBRebeca Sousa Braga
- Aline Aparecida MonroeAMAline Aparecida Monroe
Open Access
- 1 January 2026
- journal article
- review article
- Published by FapUNIFESP (SciELO) in Revista da Escola de Enfermagem da USP
- Vol. 60, e20260172
Abstract
Objective: To map studies on the coverage of the rapid molecular test for tuberculosis in different international contexts. Method: A scoping review conducted according to the PRISMA-ScR recommendations, with searches in the MEDLINE, Scopus, Web of Science, Embase, LILACS, and BDTD databases, covering the period from 2011 to 2025. Results: The 20 included studies revealed conceptual heterogeneity in the operationalization of coverage, ranging from proportions of testing in specific population groups to indicators of equipment availability and geographic accessibility, with no standardization across countries and contexts. Values ranged from less than 1% to approximately 80%, with marked differences across countries, target populations, and analyzed periods. Socioeconomic, structural, financial, and facility-access challenges hinder the use of the test. Conclusion: Test coverage varies across countries and contexts, limited by structural and financial barriers and by the lack of conceptual and methodological standardization in its measurement. Expanding and monitoring coverage in a comparable way requires governmental commitment, decentralization, and the adoption of uniform criteria aligned with World Health Organization guidelines.Keywords
This publication has 25 references indexed in Scilit:
- Nationwide coverage of molecular drug susceptibility testing in patients with pulmonary multidrug/rifampicin-resistant tuberculosis in South Korea: a retrospective cohort study (2015–2021)BMJ Open Respiratory Research, 2025
- Characterization of the targeted universal tuberculosis testing care cascade among people with HIV in PEPFAR-supported districts in South AfricaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2025
- Barriers That Interfere with Access to Tuberculosis Diagnosis and Treatment across Countries Globally: A Systematic ReviewACS Infectious Diseases, 2024
- Evaluation of a population-wide, systematic screening initiative for tuberculosis on Daru island, Western Province, Papua New GuineaBMC Public Health, 2024
- Unlocking the health system barriers to maximise the uptake and utilisation of molecular diagnostics in low-income and middle-income country settingBMJ Global Health, 2021
- Will more sensitive diagnostics identify tuberculosis missed by clinicians? Evaluating Xpert MTB/RIF testing in GuatemalaGaceta Sanitaria, 2020
- Effect of the Xpert MTB/RIF on the detection of pulmonary tuberculosis cases and rifampicin resistance in Shanghai, ChinaBMC Infectious Diseases, 2020
- The impact of implementing a Xpert MTB/RIF algorithm on drug-sensitive pulmonary tuberculosis: a retrospective analysisEpidemiology and Infection, 2017
- How is Xpert MTB/RIF being implemented in 22 high tuberculosis burden countries?European Respiratory Journal, 2014
- The Concept of AccessMedical Care, 1981